AIIMS building in Haryana's Jhajjar to be used exclusively to treat COVID-19 patients: ICMR Director-General

AIIMS building in Haryana's Jhajjar will be used exclusively to treat COVID-19 patients, the Indian Council of Medical Research (ICMR) Director-General Balram Bhargava said here on Sunday.

"AIIMS building in Haryana's Jhajjar, which has 800 beds, will be used exclusively to treat COVID-19 patients," said Bhargava while addressing a press conference here.

"60 private labs have registered so far to conduct tests. Many of them are being approved as we speak," he said. (ANI)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)